De-correlating immune checkpoint inhibitor toxicity and response in melanoma via the microbiome

被引：0
|
作者：
Williams, Nyelia
Wheeler, Caroline E.
Husain, Marium
Hoyd, Rebecca
Meara, Alexa Simon
Lynn, Mari
Bibi, Amna
Conrad, Bailey
Gray, Shannon
Bodnar, Michael
Arya, Namrata
Roberts, Scott
Hoang, Phuong
Apparicio, Jessica
Merrill, Deanna
Wu, Richard Cheng Han
Verschraegen, Claire F.
Burd, Christin Elizabeth
Kendra, Kari Lynn
Spakowicz, Daniel
机构：
[1] Ohio State Univ, Div Med Oncol, Dept Internal Med, Columbus, OH USA
[2] Ohio State Univ, Div Med Oncol, Dept Internal Med, Coll Med, Columbus, OH USA
[3] Ohio State Univ, Med Ctr, Columbus, OH USA
[4] Ohio State Univ, Wexner Med Ctr, Columbus, OH USA
[5] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH USA
[6] Ohio State Univ, Columbus, OH USA
[7] Ohio State Coll Med, Columbus, OH USA
[8] Univ S Florida, Tampa, FL USA
[9] Mayo Clin, Rochester, MN USA
[10] James Canc Hosp, Columbus, OH USA
[11] Solove Res Inst, Columbus, OH USA
[12] Ohio State Univ, James Canc Ctr, Columbus, OH USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9569
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Novel Molecular Determinants of Response or Resistance to Immune Checkpoint Inhibitor Therapies in Melanoma
    Zhang, Wenjing
    Kong, Yujia
    Li, Yuting
    Shi, Fuyan
    Lyu, Juncheng
    Sheng, Chao
    Wang, Suzhen
    Wang, Qinghua
    FRONTIERS IN IMMUNOLOGY, 2022, 12
  • [22] The role of the microbiome in immune checkpoint inhibitor colitis and hepatitis
    Ryan, Thomas
    Ling, Sophia
    Trinh, Andrew
    Segal, Jonathan P.
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2024, 72
  • [23] Insights on Immune Checkpoint Inhibitor Therapy Toxicity
    不详
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 116 (02) : 272 - 272
  • [24] Toxicity in the era of immune checkpoint inhibitor therapy
    Keam, Synat
    Turner, Naimah
    Kugeratski, Fernanda G.
    Rico, Rene
    Colunga-Minutti, Jocelynn
    Poojary, Rayansh
    Alekseev, Sayan
    Patel, Anisha B.
    Li, Yuanteng Jeff
    Sheshadri, Ajay
    Loghin, Monica E.
    Woodman, Karin
    Aaroe, Ashley E.
    Hamidi, Sarah
    Iyer, Priyanka Chandrasekhar
    Palaskas, Nicolas L.
    Wang, Yinghong
    Nurieva, Roza
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [25] Frailty and checkpoint inhibitor toxicity in older patients with melanoma
    Bruijnen, Cheryl P.
    Koldenhof, Jose J.
    Verheijden, Rik J.
    van den Bos, Frederiek
    Emmelot-Vonk, Marielle H.
    Witteveen, Petronella O.
    Suijkerbuijk, Karijn P. M.
    CANCER, 2022, 128 (14) : 2746 - 2752
  • [26] Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
    Sophia Bylsma
    Karen Yun
    Sandip Patel
    Michael J Dennis
    Current Treatment Options in Oncology, 2022, 23 : 1153 - 1168
  • [27] Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
    Bylsma, Sophia
    Yun, Karen
    Patel, Sandip
    Dennis, Michael J.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2022, 23 (09) : 1153 - 1168
  • [28] At the Heart of Immune checkpoint Inhibitor-Induced Immune Toxicity
    Young, Arabella
    Bluestone, Jeffrey A.
    CANCER DISCOVERY, 2021, 11 (03) : 537 - 539
  • [29] Identifying determinants of melanoma response to immune checkpoint inhibitors via preclinical modeling
    Day, Chi-Ping
    El Meskini, Rajaa
    Graff-Cherry, Carl
    Michalowski, Aleksandra
    Ohler, Zoe Weaver
    Van Dyke, Terry
    Merlino, Glenn
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)
  • [30] Immune signature as predictive marker for response to checkpoint inhibitor immunotherapy and overall survival in melanoma
    Krebs, Franziska K.
    Trzeciak, Emily R.
    Zimmer, Sophia
    Oezistanbullu, Deniz
    Mitzel-Rink, Heidrun
    Meissner, Markus
    Grabbe, Stephan
    Loquai, Carmen
    Tuettenberg, Andrea
    CANCER MEDICINE, 2021, 10 (05): : 1562 - 1575
12345